Back
ClearPoint Neuro Vs. Perspective Therapeutics Industry Stock Comparison
Sell
23
CLPT
ClearPoint Neuro
Last Price:
5.43
Seasonality Move:
-7.24%
Buy
81
CATX
Perspective Therapeutics
Last Price:
1.72
Seasonality Move:
1.64%
Sell
23
ClearPoint Neuro (CLPT)
is a Sell
Is ClearPoint Neuro a Buy, Sell or Hold?
- The current ClearPoint Neuro [CLPT] share price is $5.40. The Score for CLPT is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- CLPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
81
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.70. The Score for CATX is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
CLPT Stock Price Chart
What is ClearPoint Neuro's stock price today?
-
The ClearPoint Neuro share price today is $5.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLPT is experiencing selling pressure, which indicates risk of future bearish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing slight buying pressure.
CLPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 36.12 | Sell |
| Chaikin Money Flow: | -73867 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.37 - 6.43) | Sell |
| Bollinger Bands (100): | (5.99 - 7.31) | Sell |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 66.64 | Buy |
| Chaikin Money Flow: | 186227 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.37 - 1.63) | Buy |
| Bollinger Bands (100): | (0.49 - 1.35) | Buy |
CLPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.39 | Buy |
| 20-day SMA: | 5.71 | Sell |
| 50-day SMA: | 6.36 | Sell |
| 200-day SMA: | 6.12 | Sell |
| 8-day EMA: | 5.42 | Sell |
| 20-day EMA: | 5.69 | Sell |
| 50-day EMA: | 6.15 | Sell |
| 200-day EMA: | 6.63 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.64 | Buy |
| 20-day SMA: | 1.54 | Buy |
| 50-day SMA: | 1.28 | Buy |
| 200-day SMA: | 0.64 | Buy |
| 8-day EMA: | 1.63 | Buy |
| 20-day EMA: | 1.53 | Buy |
| 50-day EMA: | 1.31 | Buy |
| 200-day EMA: | 0.8 | Buy |
ClearPoint Neuro Earnings Growth & CLPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.05 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ClearPoint Neuro Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||